62nd ASH Annual Meeting and Exposition: A Discussion of Efficacy and Safety on a Treatment Option for Adults With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant.

denotes that this is a recommended PHD Trainee Session.

denotes that this is a ticketed session.

A Discussion of Efficacy and Safety on a Treatment Option for Adults With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Sponsor: Pfizer

Product Theaters

Richa Shah, PharmD

Pfizer, New York, NY

See more of: Product Theaters